<DOC>
	<DOCNO>NCT00403559</DOCNO>
	<brief_summary>This exploratory study determine effectiveness Elidel treatment seborrheic dermatitis</brief_summary>
	<brief_title>A 4 Week Study Elidel Treatment Seborrheic Dermatitis</brief_title>
	<detailed_description>This 4 week study patient 18 olderto compare efficacy safety pimecrolimus cream 1 % twice daily ketaconazole cream 2 % twice daily treatment seborrheic dermatitis .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Seborrheic</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<criteria>Must 18 old sign write informed consent . Must wiling able comply protocol . Must active seborrheic dermatitis face . No history overt bacterial , viral fungal infection head/neck . No history presence compromise dermatosis elsewhere skin No Parkinson 's disease , HIV , infection disorder central nervous system No actinically damage skin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>seborrheic dermatitis</keyword>
</DOC>